Hims & Hers Health Inc. Class A (NYSE: HIMS) stock closed at 7.15 per share at the end of the most recent trading day (a 0.85% change compared to the prior day closing price) with a volume of 1.80M shares and market capitalization of 1.48B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Consumer Packaged Goods industry, Consumer Defensive sector and employs 181 people. Hims & Hers Health Inc. Class A CEO is Andrew Dudum.

The one-year performance of Hims & Hers Health Inc. Class A stock is -14.58%, while year-to-date (YTD) performance is 9.16%. HIMS stock has a five-year performance of %. Its 52-week range is between 2.72 and 9.35, which gives HIMS stock a 52-week price range ratio of 66.67%

Hims & Hers Health Inc. Class A currently has a PE ratio of -16.90, a price-to-book (PB) ratio of 4.60, a price-to-sale (PS) ratio of 3.77, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -24.16%, a ROC of -26.71% and a ROE of -28.73%. The company’s profit margin is -22.21%, its EBITDA margin is -20.20%, and its revenue ttm is $373.75 Million , which makes it $1.88 revenue per share.

Of the last four earnings reports from Hims & Hers Health Inc. Class A, there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Hims & Hers Health Inc. Class A’s next earnings report date is -.

The consensus rating of Wall Street analysts for Hims & Hers Health Inc. Class A is Hold (2.67), with a target price of $5.96, which is -16.29% compared to the current price. The earnings rating for Hims & Hers Health Inc. Class A stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Hims & Hers Health Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Hims & Hers Health Inc. Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 56.85, ATR14 : 0.43, CCI20 : 152.61, Chaikin Money Flow : 0.21, MACD : 0.47, Money Flow Index : 75.14, ROC : 23.92, RSI : 55.29, STOCH (14,3) : 95.78, STOCH RSI : 1.00, UO : 59.12, Williams %R : -4.22), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Hims & Hers Health Inc. Class A in the last 12-months were: Alex Bard (Option Excercise at a value of $0), Ambar Bhattacharyya (Option Excercise at a value of $0), Andrea G. Perez Garcia (Option Excercise at a value of $0), Andrew Dudum (Buy at a value of $488 467), Andrew Dudum (Option Excercise at a value of $0), David Wells (Buy at a value of $1 184 191), David Wells (Option Excercise at a value of $0), Irene Becklund (Option Excercise at a value of $0), Irene Becklund (Sold 19 331 shares of value $96 655 ), Jules A. Maltz (Buy at a value of $473 994), Jules A. Maltz (Option Excercise at a value of $0), Kirsten A. Green (Option Excercise at a value of $0), Lynne Chou O¿Keefe (Option Excercise at a value of $0), Lynne Chou O¿Keefe (Sold 60 267 shares of value $291 391 ), Melissa Baird (Option Excercise at a value of $48 024), Oluyemi Okupe (Buy at a value of $26 399), Soleil Boughton (Option Excercise at a value of $0), Soleil Boughton (Sold 73 548 shares of value $328 760 )